Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of BIRT 2584 in Healthy Volunteers
NCT02259894Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2004
- Primary completion
- Jun 2004
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in multiple sclerosis (MS) comparing BIRT 2584 with Placebo (2 arms). Primary endpoints: Number of participants with adverse events, Number of participants with clinically significant changes in vital signs and 3 more. Started Mar 2004; status: completed.
02
Drugs
BIRT 2584 XX
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02259894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259894.